Buy or sell Nerium Biotechnology stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Nerium Biotechnology Stock

Nerium Biotechnology engages in the development of oleander-based products for the treatment of proliferative diseases and viral infections.

About Nerium Biotechnology Stock

Nerium Biotechnology, Inc., a biotechnology company, engages in the development of oleander-based products for the treatment of certain forms of proliferative diseases and viral infections. Its lead product includes Anvirzel, which is used to treat various forms of cancer. The company’s product line also comprises HIviral for the treatment of HIV/AIDS; HEP-viral for the treatment of hepatitis C; and NeriumAD, a skin cream for age-defying treatment. Nerium Biotechnology, Inc. is based in San Antonio, the United States.

Funding History

March 2011$289K

Management

Director

John F. O'Donnell

CEO & Chairman of the Board of Directors

Dennis Ray Knocke

CFO

Joseph B. Nester

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Nerium Biotechnology or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo